Pharmaceutical / Drug Definition :
Exerts anticholinergic, CNS depressant, and antihistaminic effects. Depresses release of hypothalamic and hypophyseal hormones, decreases sensitivity of middle-ear labyrinth, and reduces conduction in vestibular-cerebellar pathways.
FDA Label Requirements and Exceptions
Prochlorperazine Edisylate
FDA Import Information
Prochlorperazine Edisylate
FDA Detentions
Prochlorperazine Edisylate (Prochlorperazine Edisylate Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Prochlorperazine Edisylate (Prochlorperazine Edisylate Suppliers)
- Processors Prochlorperazine Edisylate
- Repackers Prochlorperazine Edisylate
- Relabelers Prochlorperazine Edisylate
- Exporters Prochlorperazine Edisylate
- Importers Prochlorperazine Edisylate
For more information about Prochlorperazine Edisylate, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
